Abpro Holdings, Inc. 8-K

What Happened

• Abpro Holdings, Inc. announced that on February 18, 2026 it received notice from the Nasdaq Hearings Panel that its securities will be delisted and trading suspended at the open of trading on February 23, 2026. Nasdaq’s action follows the Company’s failure to meet the Panel’s November 10, 2025 requirement to demonstrate compliance with the minimum equity standard under Nasdaq Listing Rule 5550(b)(1) by February 16, 2026. The Company expects to appeal the Panel’s decision.

Key Details

• Date of notice: February 18, 2026; scheduled suspension of trading: open of trading on February 23, 2026.
• Prior Panel decision: November 10, 2025 required compliance with Nasdaq Listing Rule 5550(b)(1) (minimum equity) by February 16, 2026.
• Appeal window: Company has 15 days from receipt of the notice to request review by the Nasdaq Listing and Hearing Review Council and expects to appeal.
• If no successful appeal, Nasdaq is expected to file a Form 25 to delist and deregister the securities under Section 12(b); after suspension the Company expects its common stock and public warrants may be eligible for quotation on the OTC Pink Market under symbols “ABP” and “ABPWW,” but there is no assurance of market makers, liquidity, or continued quotations.

Why It Matters

• Delisting from Nasdaq and a move to the OTC Pink Market can reduce liquidity, increase volatility, and limit the availability of reliable public information, making buying or selling shares and warrants potentially more difficult and riskier for retail investors.
• Deregistration under Section 12(b) would change reporting and regulatory dynamics for the company and could further reduce institutional interest.
• The Company’s appeal opportunity may delay final delisting, but investors should be prepared for possible suspension of Nasdaq trading and the risks outlined above.